Teladoc Health GAAP EPS of -$0.28 misses by $0.02, revenue of $626.44M in-line

The outlook provided below is based on current market conditions and expectations and what we know today.

For the fourth quarter of 2025, we expect:
	4Q 2025 Outlook Range
Revenue	$622 – $652 million vs consensus of $634.86M
Adjusted EBITDA	$73 – $90 million
Net loss per share	($0.25) – ($0.10) vs consensus of ($0.23)
U.S. Integrated Care Members (2)	101.5 – 102.5 million